Singapore markets closed

Bio-Techne Corporation (TECH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
284.00-1.63 (-0.57%)
At close: 04:00PM EDT
284.00 0.00 (0.00%)
After hours: 04:49PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.20B
Enterprise value 11.28B
Trailing P/E 43.08
Forward P/E 33.00
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)10.60
Price/book (mrq)6.58
Enterprise value/revenue 10.20
Enterprise value/EBITDA 27.27

Trading information

Stock price history

Beta (5Y monthly) 1.25
52-week change 3-40.98%
S&P500 52-week change 3-16.62%
52-week high 3531.80
52-week low 3281.42
50-day moving average 3342.82
200-day moving average 3384.06

Share statistics

Avg vol (3-month) 3217.73k
Avg vol (10-day) 3281.29k
Shares outstanding 539.22M
Implied shares outstanding 6N/A
Float 838.89M
% held by insiders 10.77%
% held by institutions 196.11%
Shares short (14 Sept 2022) 4700.52k
Short ratio (14 Sept 2022) 43.56
Short % of float (14 Sept 2022) 42.32%
Short % of shares outstanding (14 Sept 2022) 41.79%
Shares short (prior month 14 Aug 2022) 4551.71k

Dividends & splits

Forward annual dividend rate 41.28
Forward annual dividend yield 40.45%
Trailing annual dividend rate 31.28
Trailing annual dividend yield 30.45%
5-year average dividend yield 40.56
Payout ratio 419.31%
Dividend date 328 Aug 2022
Ex-dividend date 411 Aug 2022
Last split factor 22:1
Last split date 303 Dec 2000

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2022
Most-recent quarter (mrq)29 Jun 2022


Profit margin 24.61%
Operating margin (ttm)27.09%

Management effectiveness

Return on assets (ttm)8.21%
Return on equity (ttm)16.08%

Income statement

Revenue (ttm)1.11B
Revenue per share (ttm)28.19
Quarterly revenue growth (yoy)11.30%
Gross profit (ttm)758.09M
EBITDA 359.93M
Net income avi to common (ttm)271.93M
Diluted EPS (ttm)6.63
Quarterly earnings growth (yoy)311.30%

Balance sheet

Total cash (mrq)247.03M
Total cash per share (mrq)6.3
Total debt (mrq)326.45M
Total debt/equity (mrq)19.19
Current ratio (mrq)3.44
Book value per share (mrq)43.46

Cash flow statement

Operating cash flow (ttm)325.27M
Levered free cash flow (ttm)226.97M